A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- United States of America
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Vaginal fluid Vaginal discharge,Vaginal secretion,Vaginal fluid,vaginal fluid
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bacterial vaginosis BACT VAGINITIDES,BACT VAGINITIS,BACT VAGINOSES,BACT VAGINOSIS,Bacterial Vaginitides,Bacterial Vaginitis,Bacterial Vaginoses,bacterial vaginosis,BV,Nonspecific Vaginitis,VAGINITIDES BACT,Vaginitides, Bacterial,VAGINITIS BACT,Vaginitis, Bacterial,Vaginitis, Nonspecific,VAGINOSES BACT,Vaginoses, Bacterial,VAGINOSIS BACT,Vaginosis, Bacterial,Bacterial vaginosis
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- vaginal delivery
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- cesarean section
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- women reported birth by C-section
- Group 0 sample size Number of subjects in the control (unexposed) group
- 117
- Group 1 sample size Number of subjects in the case (exposed) group
- 27
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- women reported birth by vaginal delivery
Lab analysis
- Sequencing type
- PCR
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 4
Signature 1
Source: Figure 2
Description: The bacterial taxa with the highest effect sizes (linear discriminant analysis [LDA] scores > 4) reflect marked abundance in one birth mode group and not in the other. Three taxa were differentially abundant at this level, with P. bivia being more abundant in C-section-delivered group and L. jensenii and L. iners being more abundant in the vaginally-delivered group. However, these differences were not statistically significant (0.05 < p < 0.30).
Abundance in Group 1: increased abundance in cesarean section
NCBI | Quality Control | Links |
---|---|---|
Prevotella bivia |
Revision editor(s): Danyab56
Signature 2
Source: Figure 2
Description: The bacterial taxa with the highest effect sizes (linear discriminant analysis [LDA] scores > 4) reflect marked abundance in one birth mode group and not in the other. Three taxa were differentially abundant at this level, with P. bivia being more abundant in C-section-delivered group and L. jensenii and L. iners being more abundant in the vaginally-delivered group. However, these differences were not statistically significant (0.05 < p < 0.30).
Abundance in Group 1: decreased abundance in cesarean section
NCBI | Quality Control | Links |
---|---|---|
Lactobacillus jensenii | ||
Lactobacillus iners |
Revision editor(s): Danyab56